Cargando…
Challenges in Diagnosing Intermediate Maple Syrup Urine Disease by Newborn Screening and Functional Validation of Genomic Results Imperative for Reproductive Family Planning
Maple syrup urine disease is caused by a deficiency of branched-chain alpha-ketoacid dehydrogenase, responsible for degradation of leucine, isoleucine, and valine. Biallelic pathogenic variants in BCKDHA, BCKDHB, or DBT genes result in enzyme deficiency. We report the case of a female infant who pre...
Autores principales: | Sajeev, Mona, Chin, Sharon, Ho, Gladys, Bennetts, Bruce, Sankaran, Bindu Parayil, Gutierrez, Bea, Devanapalli, Beena, Tolun, Adviye Ayper, Wiley, Veronica, Fletcher, Janice, Fuller, Maria, Balasubramaniam, Shanti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162326/ https://www.ncbi.nlm.nih.gov/pubmed/34069211 http://dx.doi.org/10.3390/ijns7020025 |
Ejemplares similares
-
A narrative review of metabolomics in the era of “-omics”: integration into clinical practice for inborn errors of metabolism
por: Hertzog, Ashley, et al.
Publicado: (2022) -
The use of sodium DL-3-Hydroxybutyrate in severe acute neuro-metabolic compromise in patients with inherited ketone body synthetic disorders
por: Bhattacharya, Kaustuv, et al.
Publicado: (2020) -
Neuroradiological findings in maple syrup urine disease
por: Indiran, Venkatraman, et al.
Publicado: (2013) -
Intramyelinic edema in maple syrup urine disease
por: Cornelius, Leema Pauline, et al.
Publicado: (2014) -
Maple syrup urine disease: mechanisms and management
por: Blackburn, Patrick R, et al.
Publicado: (2017)